South & Central America Mid-Size Pharmaceutical Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Prescription and Over-the-Counter), Drug Development Type (In-House and Outsource), Formulation (Tablets and Capsules, Injectables, Sprays, and Other Formulations), and Therapy Class (Cardiovascular Diseases, Pain Management, Diabetes, Cancer, and Other Conditions)
The mid-size pharmaceutical market in South & Central America is expected to grow from US$ 24,301.56 million in 2022 to US$ 31,118.17 million by 2028; it is estimated to grow at a CAGR of 4.2% from 2022 to 2028.
The South & Central America mid-size pharmaceutical market is segmented into Brazil, Argentina, and the Rest of South & Central America. In the global market, SAM held the second smallest share of US$ 24,301.56 million in 2022. The growth of the SAM market is driven by the increasing prevalence of cancer, rising geriatric population, surging incidence of hypertension, and the growing prevalence of other chronic diseases. The mid-size pharmaceutical market in the Rest of South & Central America is sub segmented into Peru, Chile, Bolivia, Ecuador, and other countries. According to the GLOBOCAN 2020, prostate cancer is the leading cause of cancer death in the Peruvian population, with an age-standardized mortality rate (ASMR) of 44.3 per 100,000. Due to the rising cancer prevalence, the demand for oncology drugs is expected to rise in the region, which would create lucrative opportunities for the mid-size pharmaceutical companies.
By introducing new features and technologies, vendors in the South & Central America mid-size pharmaceutical market can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the market growth at a good CAGR during the forecast period.
South & Central America Mid-Size Pharmaceutical Market Revenue and Forecast to 2028 (US$ Million)
South & Central America Mid-Size Pharmaceutical Market Segmentation
The South & Central America mid-size pharmaceutical market is segmented on the basis of type, drug development type, formulation, therapy class, and country.
Based on type, the South & Central America mid-size pharmaceutical market is bifurcated into prescription and over-the-counter. In 2022, the over-the-counter segment accounted for a larger market share. Based on drug development type, the market is bifurcated into in-house and outsource. The outsource segment held a larger market share in 2022. Based on formulation, the South & Central America mid-size pharmaceutical market is segmented into tablets and capsules, injectables, sprays, and other formulations. The tablets & capsules segment held the largest market share in 2022. Based on therapy class, the market is segmented into cardiovascular diseases, pain management, diabetes, cancer, and other conditions. The diabetes segment held the largest market share in 2022. Based on country, the South & Central America mid-size pharmaceutical market is segmented into Brazil, Argentina, and Rest of South & Central America. Brazil held the largest market share in 2022.
Alexion Pharmaceuticals, Inc.; Bausch Health Companies Inc.; Daiichi Sankyo Company Limited; Endo Pharmaceuticals Inc.; Mallinckrodt; and Sun Pharmaceutical Industries Ltd are among the leading companies operating in the mid-size pharmaceutical market in the region.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 SAM Mid-Size Pharmaceutical – By Type
1.3.2 SAM Mid-Size Pharmaceutical – By Drug Development Type
1.3.3 SAM Mid-Size Pharmaceutical – By Formulation
1.3.4 SAM Mid-Size Pharmaceutical – By Therapy Area
1.3.5 SAM Mid-Size Pharmaceutical – By Country
2. South & Central America Mid-Size Pharmaceutical– Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. SAM Mid-Size Pharmaceutical – Market Landscape
4.1 Overview
4.2 SAM PEST Analysis
4.3 Expert Opinion
5. South & Central America Mid-Size Pharmaceutical Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Chronic Disorders
5.1.2 Increasing Product Approval and Launches
5.2 Market Restraints
5.2.1 High Competition Among Market Players
5.3 Market Opportunities
5.3.1 Rising Number of Healthcare Start-ups
5.4 Future Trends
5.4.1 Increasing Focus on R&D
5.5 Impact Analysis
6. Mid-Size Pharmaceutical Market– SAM Analysis
6.1 SAM Mid-Size Pharmaceutical Market Revenue Forecast and Analysis
7. SAM Mid-Size Pharmaceutical Market Revenue and Forecasts To 2028– by Type
7.1 Overview
7.2 SAM Mid-Size Pharmaceutical Market Revenue Share, by Type (2022 and 2028)
7.3 Prescription
7.3.1 Overview
7.3.2 Prescription: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Over-the-Counter (OTC)
7.4.1 Overview
7.4.2 Over-the-Counter: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
8. SAM Mid-Size Pharmaceutical Market Analysis – By Drug Development Type
8.1 Overview
8.2 SAM Mid-Size Pharmaceutical Market Revenue Share, by Drug Development Type (2022 and 2028)
8.3 In-House
8.3.1 Overview
8.3.2 In-House: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Outsource
8.4.1 Overview
8.4.2 Outsource: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
9. SAM Mid-Size Pharmaceutical Market – By Formulation
9.1 Overview
9.2 SAM Mid-Size Pharmaceutical Market, by Formulation, 2022 and 2028 (%)
9.3 Tablets and Capsules
9.3.1 Overview
9.3.2 Tablets and Capsules: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Injectables
9.4.1 Overview
9.4.2 Injectables: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Sprays
9.5.1 Overview
9.5.2 Sprays: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Other Formulations
9.6.1 Overview
9.6.2 Others: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
10. SAM Mid-Size Pharmaceutical Market – By Therapy Class
10.1 Overview
10.2 SAM Mid-Size Pharmaceutical Market, by Therapy Class, 2022 and 2028 (%)
10.3 Cardiovascular Diseases
10.3.1 Overview
10.3.2 Cardiovascular Diseases: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
10.4 Pain Management
10.4.1 Overview
10.4.2 Pain Management: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
10.5 Diabetes
10.5.1 Overview
10.5.2 Diabetes: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
10.6 Cancer
10.6.1 Overview
10.6.2 Cancer: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
10.7 Other Diseases
10.7.1 Overview
10.7.2 Other Diseases: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
11. SAM Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028 – Country Analysis
11.1 Overview
11.1.1 SAM: Mid-Size Pharmaceutical Market, by country, 2021 & 2028 (%)
11.1.1.1 Brazil: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million)
11.1.1.1.1 Brazil: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million)
11.1.1.1.2 Brazil: Mid-Size Pharmaceutical Market, by Type, 2019–2028 (USD Million)
11.1.1.1.3 Brazil: Mid-Size Pharmaceutical Market, by Drug Development Type, 2019–2028 (USD Million)
11.1.1.1.4 Brazil: Mid-Size Pharmaceutical Market, by Formulation, 2019–2028 (USD Million)
11.1.1.1.5 Brazil: Mid-Size Pharmaceutical Market, by Therapy Area, 2019–2028 (USD Million)
11.1.1.2 Argentina: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million)
11.1.1.2.1 Argentina: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million)
11.1.1.2.2 Argentina: Mid-Size Pharmaceutical Market, by Type, 2019–2028 (USD Million)
11.1.1.2.3 Argentina: Mid-Size Pharmaceutical Market, by Drug Development Type, 2019–2028 (USD Million)
11.1.1.2.4 Argentina: Mid-Size Pharmaceutical Market, by Formulation, 2019–2028 (USD Million)
11.1.1.2.5 Argentina: Mid-Size Pharmaceutical Market, by Therapy Area, 2019–2028 (USD Million)
11.1.1.3 Rest of SAM: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million)
11.1.1.3.1 Rest of SAM: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million)
11.1.1.3.2 Rest of SAM: Mid-Size Pharmaceutical Market, by Type, 2019–2028 (USD Million)
11.1.1.3.3 Rest of SAM: Mid-Size Pharmaceutical Market, by Drug Development Type, 2019–2028 (USD Million)
11.1.1.3.4 Rest of SAM: Mid-Size Pharmaceutical Market, by Formulation, 2019–2028 (USD Million)
11.1.1.3.5 Rest of SAM: Mid-Size Pharmaceutical Market, by Therapy Area, 2019–2028 (USD Million)
12. Mid-Size Pharmaceutical Market–Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 DAIICHI SANKYO COMPANY LIMITED
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Bausch Health Companies Inc.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Sun Pharmaceutical Industries Ltd
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Alexion Pharmaceuticals, Inc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Mallinckrodt
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Endo Pharmaceuticals Inc.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. Brazil: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 2. Brazil: Mid-Size Pharmaceutical Market, by Drug Development Type – Revenue and Forecast to 2028 (USD Million)
Table 3. Brazil: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (USD Million)
Table 4. Brazil: Mid-Size Pharmaceutical Market, by Therapy Area– Revenue and Forecast to 2028 (USD Million)
Table 5. Argentina: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 6. Argentina: Mid-Size Pharmaceutical Market, by Drug Development Type – Revenue and Forecast to 2028 (USD Million)
Table 7. Argentina: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (USD Million)
Table 8. Argentina: Mid-Size Pharmaceutical Market, by Therapy Area– Revenue and Forecast to 2028 (USD Million)
Table 9. Rest of SAM: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 10. Rest of SAM: Mid-Size Pharmaceutical Market, by Drug Development Type – Revenue and Forecast to 2028 (USD Million)
Table 11. Rest of SAM: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (USD Million)
Table 12. Rest of SAM: Mid-Size Pharmaceutical Market, by Therapy Area– Revenue and Forecast to 2028 (USD Million)
Table 13. Organic Developments Done By Companies
Table 14. Inorganic Developments Done By Companies
Table 15. Glossary of Terms
LIST OF FIGURES
Figure 1. SAM Mid-Size Pharmaceutical Segmentation
Figure 2. SAM Mid-Size Pharmaceutical Segmentation, By Country
Figure 3. SAM Mid-Size Pharmaceutical Overview
Figure 4. Over-the-Counter Segment Held Largest Share by Type in SAM Mid-Size Pharmaceutical Market
Figure 5. Brazil is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. SAM: PEST Analysis
Figure 7. SAM Mid-Size Pharmaceutical Market– Revenue Forecast And Analysis – 2020- 2028
Figure 8. SAM Mid-Size Pharmaceutical Market Revenue Share, by Type (2022 and 2028)
Figure 9. SAM Prescription: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
Figure 10. SAM Over-the-Counter: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. SAM Mid-Size Pharmaceutical Market Revenue Share, by Drug Development Type (2022 and 2028)
Figure 12. SAM In-House: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. SAM Outsource: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. SAM Mid-Size Pharmaceutical Market, by Formulation, 2022 and 2028 (%)
Figure 15. SAM Tablets and Capsules: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. SAM Injectables: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. SAM Sprays: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. SAM Others: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. SAM Mid-Size Pharmaceutical Market, by Therapy Class, 2022 and 2028 (%)
Figure 20. SAM Cardiovascular Diseases: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. SAM Pain Management: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. SAM Diabetes: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. SAM Cancer: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. SAM Other Diseases: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. SAM: Mid-Size Pharmaceutical Market, by Key Country – Revenue (2022) (US$' Million)
Figure 26. SAM: Mid-Size Pharmaceutical Market, by country, 2021 & 2028 (%)
Figure 27. Brazil: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million)
Figure 28. Argentina: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million)
Figure 29. Rest of SAM: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million)
Figure 30. Growth Strategies Done by the Companies in the Market, (%)
- Alexion Pharmaceuticals, Inc.
- Bausch Health Companies Inc.
- Daiichi Sankyo Company Limited
- Endo Pharmaceuticals Inc.
- Mallinckrodt
- Sun Pharmaceutical Industries Ltd
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the South & Central America mid-size pharmaceutical market
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the South & Central America mid-size pharmaceutical market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the mid-size pharmaceutical market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution